Dalmia Bharat Limited (BOM:542216)
2,244.05
-16.90 (-0.75%)
At close: Aug 8, 2025
Revance Therapeutics Market Cap
Dalmia Bharat has a market cap or net worth of 420.78 billion as of August 8, 2025. Its market cap has increased by 26.65% in one year.
Market Cap
420.78B
Enterprise Value
433.12B
Revenue
139.95B
Ranking
n/a
PE Ratio
45.00
Stock Price
$2,244.05
Market Cap Chart
Since December 21, 2018, Dalmia Bharat's market cap has increased from 64.30B to 420.78B, an increase of 554.41%. That is a compound annual growth rate of 32.72%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Aug 8, 2025 | 420.78B | 26.94% |
Dec 31, 2024 | 331.47B | -22.32% |
Dec 29, 2023 | 426.71B | 22.18% |
Dec 30, 2022 | 349.24B | 1.00% |
Dec 31, 2021 | 345.80B | 71.45% |
Dec 31, 2020 | 201.69B | 30.61% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
Dec 21, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Reliance Industries | 18.51T |
HDFC Bank | 15.15T |
Bharti Airtel | 11.15T |
Tata Consultancy Services | 10.99T |
ICICI Bank | 10.25T |
State Bank of India | 7,424.82B |
Infosys | 5,899.00B |
Hindustan Unilever | 5,870.69B |